Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Durect and Sandoz sign $293m deal to commercialise Posimir in US

pharmaceutical-technologyMay 10, 2017

Tag: Posimir , Sandoz

PharmaSources Customer Service